Magnolol attenuates the locomotor impairment, cognitive deficit, and neuroinflammation in Alzheimer’s disease mice with brain insulin resistance via up-regulating miR-200c

References

• Sousa JCE, Santana ACF, Magalhães GJP. Resveratrol in Alzheimer’s disease: a review of pathophysiology and therapeutic potential. Arq Neuropsiquiatr. 2020. DOI:10.1590/0004-282x20200010
   Web of Science ®Google Scholar
• Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol. 2019;167:231–255.
   PubMedGoogle Scholar
• Bao X, Liu G, Jiang Y, et al. Cell adhesion molecule pathway genes are regulated by cis-regulatory SNPs and show significantly altered expression in Alzheimer’s disease brains. Neurobiol Aging. 2015;36:2904.e1–7.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405.
   PubMed Web of Science ®Google Scholar
• Verkhratsky A, Parpura V, Rodriguez-Arellano JJ, et al. Astroglia in Alzheimer’s disease. Adv Exp Med Biol. 2019;1175:273–324.
   PubMed Web of Science ®Google Scholar
• Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s disease. J Cell Biol. 2018;217:459–472.
   PubMed Web of Science ®Google Scholar
• Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease–is this type 3 diabetes? J Alzheimers Dis. 2005;7:63–80.
   PubMed Web of Science ®Google Scholar
• de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease. Curr Alzheimer Res. 2012;9:35–66.
   PubMed Web of Science ®Google Scholar
• Akhtar A, Dhaliwal J, Saroj P, et al. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer’s-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Inflammopharmacology. 2020;28:385–400.
   PubMed Web of Science ®Google Scholar
• Dey A, Bhattacharya R, Mukherjee A, et al. Natural products against Alzheimer’s disease: pharmaco-therapeutics and biotechnological interventions. Biotechnol Adv. 2017;35:178–216.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Peng L, Hu J, et al. Current anti-Alzheimer’s disease effect of natural products and their principal targets. J Integr Neurosci. 2019;18:327–339.
   PubMed Web of Science ®Google Scholar
• Jha AB, Panchal SS, Shah A. Ellagic acid: insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer’s disease. Pharmacol Biochem Behav. 2018;175:33–46.
   PubMed Web of Science ®Google Scholar
• Ajayi AM. Chrysophyllum albidum (African star apple) fruit-supplemented diet enhances cognitive functions and attenuates lipopolysaccharide-induced memory impairment, oxidative stress, and release of proinflammatory cytokines. Nutrire. 2020;45:10–13.
   Google Scholar
• Ben-Azu B, Nwoke EE, Aderibigbe AO, et al. Possible neuroprotective mechanisms of action involved in the neurobehavioral property of naringin in mice. Biomed Pharmacothe. 2019;109:536–546.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Cheng H, et al. Ameliorating effect of luteolin on memory impairment in an Alzheimer’s disease model. Mol Med Rep. 2016;13:4215–4220.
   PubMed Web of Science ®Google Scholar
• Maione F, Piccolo M, De Vita S, et al. Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease. Pharmacol Res. 2018;129:482–490.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen Z, Huang X, et al. Insights on the multifunctional activities of magnolol. Biomed Res Int. 2019;2019:1847130.
   PubMed Web of Science ®Google Scholar
• Gao T, Xu H, Jia S, et al. Magnolol induces human Ewing sarcoma SK-ES-1 cell apoptosis via the mitochondrial and death receptor pathways. Am J Transl Res. 2020;12:1672–1682.
   PubMed Web of Science ®Google Scholar
• Sarrica A, Kirika N, Romeo M, et al. Safety and toxicology of magnolol and honokiol. Planta Med. 2018;84:1151–1164.
   PubMed Web of Science ®Google Scholar
• Chen H, Fu W, Chen H, et al. Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo. Mol Immunol. 2019;105:96–106.
   PubMed Web of Science ®Google Scholar
• Parray HA, Lone J, Park JP, et al. Magnolol promotes thermogenesis and attenuates oxidative stress in 3T3-L1 adipocytes. Nutrition. 2018;50:82–90.
   PubMed Web of Science ®Google Scholar
• Zhou S, Wen H, Li H. Magnolol induces apoptosis in osteosarcoma cells via G0/G1 phase arrest and p53-mediated mitochondrial pathway. J Cell Biochem. 2019;120:17067–17079.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang K, Ding X, et al. Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway. J Thorac Dis. 2019;11:3030–3038.
   PubMed Web of Science ®Google Scholar
• Chei S, Oh HJ, Song JH, et al. Magnolol suppresses TGF-β-induced epithelial-to-mesenchymal transition in human colorectal cancer cells. Front Oncol. 2019;9:752.
   PubMed Web of Science ®Google Scholar
• Cheng J, Dong S, Yi L, et al. Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice. Int Immunopharmacol. 2018;59:61–67.
   PubMed Web of Science ®Google Scholar
• Higaki S, Muramatsu M, Matsuda A, et al. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer’s disease models. PLoS One. 2018;13:e0196929.
   PubMed Web of Science ®Google Scholar
• Hagiwara K, Gailhouste L, Yasukawa K, et al. A robust screening method for dietary agents that activate tumour-suppressor microRNAs. Sci Rep. 2015;5:14697.
   PubMed Web of Science ®Google Scholar
• Nassar SZ, Badae NM, Issa YA. Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer’s disease. Arch Physiol Biochem. 2020;126:326–334.
   PubMed Web of Science ®Google Scholar
• Lin YR, Chen HH, Ko CH, et al. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci. 2007;81:1071–1078.
   PubMed Web of Science ®Google Scholar
• Ding B, Lin C, Liu Q, et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-kappaB signaling pathway in vivo and in vitro. J Neuroinflammation. 2020;17:302.
   PubMed Web of Science ®Google Scholar
• Yang C, Xia W, Liu X, et al. Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction. Int J Mol Med. 2019;44:417–426.
   PubMed Web of Science ®Google Scholar
• Papadaki C, Monastirioti A, and Rounis K, et al. Circulating MicroRNAs regulating DNA damage response and responsiveness to cisplatin in the prognosis of patients with non-small cell lung cancer treated with first-line platinum chemotherapy. Cancers (Basel). 2020;12:1282.
   Web of Science ®Google Scholar
• Taylor SC, Posch A. The design of a quantitative Western blot experiment. Biomed Res Int. 2014;2014:361590.
   PubMed Web of Science ®Google Scholar
• Chen MY, Fan K, Zhao LJ, et al. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson’s disease. Bioengineered. 2021;12:708–719.
   PubMed Web of Science ®Google Scholar
• Canever L, Freire TG, Mastella GA, et al. Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: the effects of FA deficient or FA supplemented diet during the neurodevelopmental phase. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:52–64.
   PubMed Web of Science ®Google Scholar
• Fukui K, Omoi NO, Hayasaka T, et al. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann NY Acad Sci. 2002;959:275–284.
   PubMed Web of Science ®Google Scholar
• Li Q, Song W, Tian Z, et al. Aminoguanidine alleviated MMA-induced impairment of cognitive ability in rats by downregulating oxidative stress and inflammatory reaction. Neurotoxicology. 2017;59:121–130.
   PubMed Web of Science ®Google Scholar
• López-Riquelme N, Alom-Poveda J, Viciano-Morote N, et al. Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer’s disease. SAGE Open Med. 2016;4:2050312115626731.
   Web of Science ®Google Scholar
• Zabel M, Nackenoff A, Kirsch WM, et al. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer’s disease brain: a meta-analysis in human pathological specimens. Free Radic Biol Med. 2018;115:351–360.
   PubMed Web of Science ®Google Scholar
• Luo H, Xiang Y, Qu X, et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of alzheimer’s disease through activation of BDNF-TrkB signaling pathway. Front Pharmacol. 2019;10:395.
   PubMed Web of Science ®Google Scholar
• Ng A, Tam WW, Zhang MW, et al. IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis. Sci Rep. 2018;8:12050.
   PubMed Web of Science ®Google Scholar